Acuta Capital Partners, LLC Terns Pharmaceuticals, Inc. Transaction History
Acuta Capital Partners, LLC
- $52.7 Million
- Q1 2025
A detailed history of Acuta Capital Partners, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 325,550 shares of TERN stock, worth $983,161. This represents 1.7% of its overall portfolio holdings.
Number of Shares
325,550
Previous 447,500
27.25%
Holding current value
$983,161
Previous $2.5 Million
64.04%
% of portfolio
1.7%
Previous 3.55%
Shares
10 transactions
Others Institutions Holding TERN
# of Institutions
143Shares Held
84.5MCall Options Held
256KPut Options Held
133K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$24.7 Million1.87% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$22.8 Million0.65% of portfolio
-
Morgan Stanley New York, NY7.11MShares$21.5 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$20.8 Million5.17% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$16.8 Million0.54% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $114M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...